Novel Peptide NIRF Optical Surgical Navigation Agents for HNSCC

Head and neck squamous cell carcinoma (HNSCC) survival rates have not improved in a decade, with a 63% 5-year recurrence rate after surgery, making HNSCC a compelling indication for optical surgical navigation (OSN). A promising peptide, HN1, targeted and internalized in human HNSCC cells in multipl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Haiming, Kothandaraman, Shankaran, Gong, Li, Wright, Chadwick L., Pan, Quintin, Teknos, Theodore, Tweedle, Michael F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749330/
https://www.ncbi.nlm.nih.gov/pubmed/31450798
http://dx.doi.org/10.3390/molecules24173070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749330/
https://www.ncbi.nlm.nih.gov/pubmed/31450798
http://dx.doi.org/10.3390/molecules24173070

Ejemplares similares